October 7, 2016 / 12:41 PM / 10 months ago

BRIEF-Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil

Oct 7 (Reuters) - Neptune Technologies & Bioressources Inc

* Terms also cover potential collaboration between both companies on clinical trials

* Neptune Technologies & Bioressources Inc says all other terms of agreement remain confidential

* Neptune and Ingenutra sign an exclusive worldwide agreement for Maxsimil

* All other terms of agreement remain confidential.

* Agreement allows neptune to manufacture, distribute and sell Maxsimil in nutraceutical field worldwide

* Says agreement is valid till 2028 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below